Quantum Biopharma Ltd. Files May 2025 6-K Report

Ticker: QNTM · Form: 6-K · Filed: May 30, 2025 · CIK: 1771885

Quantum Biopharma Ltd. 6-K Filing Summary
FieldDetail
CompanyQuantum Biopharma Ltd. (QNTM)
Form Type6-K
Filed DateMay 30, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: reporting, foreign-private-issuer, sec-filing

TL;DR

Quantum Biopharma (fka FSD Pharma) filed their May 6-K, confirming they're a Canadian foreign private issuer using Form 20-F.

AI Summary

Quantum Biopharma Ltd. filed a Form 6-K on May 30, 2025, reporting for the month of May 2025. The company, formerly known as FSD Pharma Inc. until March 27, 2019, is a foreign private issuer based in Toronto, Canada. They are filing under the 1934 Act and will file annual reports under Form 20-F.

Why It Matters

This filing provides routine updates for investors and regulators regarding Quantum Biopharma Ltd.'s activities and compliance as a foreign private issuer.

Risk Assessment

Risk Level: low — This is a routine filing (6-K) that does not contain new material financial information or significant operational updates.

Key Players & Entities

  • Quantum Biopharma Ltd. (company) — Filer
  • FSD Pharma Inc. (company) — Former company name
  • May 30, 2025 (date) — Filing date
  • 20250530 (date) — Period of report
  • 001-39152 (other) — SEC file number
  • Form 20-F (document) — Annual report form
  • Form 6-K (document) — Report type

FAQ

What is the primary purpose of this Form 6-K filing?

The Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of May 2025.

What was Quantum Biopharma Ltd.'s former name?

Quantum Biopharma Ltd.'s former company name was FSD Pharma Inc., with a date of name change on March 27, 2019.

Where is Quantum Biopharma Ltd. located?

Quantum Biopharma Ltd. is located at 55 University Ave., Suite 1003, Toronto, Ontario M5J2H7, Canada.

Which form will Quantum Biopharma Ltd. use for its annual reports?

Quantum Biopharma Ltd. indicates it files or will file annual reports under cover of Form 20-F.

What is the SIC code for Quantum Biopharma Ltd.?

The Standard Industrial Classification (SIC) code for Quantum Biopharma Ltd. is 2834, Pharmaceutical Preparations.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on May 30, 2025 regarding Quantum Biopharma Ltd. (QNTM).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.